Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Disulfiram
(D00131)		1件: Disulfiram1件: Disulfiram (D00131) 💬 3件: ALDH1B1,
ALDH2,
ALDH3A2 💬 		13件: Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬3件: 46, 90, 301 💬
2Disulfiram (DSF)
(D00131)		1件: Disulfiram1件: Disulfiram (D00131) 💬 3件: ALDH1B1,
ALDH2,
ALDH3A2 💬 		13件: Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 46 💬
3Oral disulfiram
(D00131)		1件: Disulfiram1件: Disulfiram (D00131) 💬 3件: ALDH1B1,
ALDH2,
ALDH3A2 💬 		13件: Alcoholic liver disease, Arginine and proline metabolism, Ascorbate and aldarate metabolism, Fatty acid degradation, Glycerolipid metabolism, Glycolysis / Gluconeogenesis, Histidine metabolism, Lysine degradation, Pantothenate and CoA biosynthesis, Pyruvate metabolism, Tryptophan metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬2件: 90, 301 💬